As one of the pro-angiogenic factors, AFP can promote the abnormal proliferation of blood vessels by binding to vascular endothelial growth factor receptor 2 (VEGFR2), increase the permeability and structural instability of tumor blood vessels, and accelerate the process of hematogenous metastasis (26). Here, KDR is linked to neoplasm.